FICHA FARMACOLÓGICA de cinacalcet. Contiene la Monografía en distintos idiomas (de la Comunidad Económica Europea), así como la discusión científica que sustenta su aprobación terapéutica. Para acceder a la monografía en idioma español, hacer doble clik en la sigla (es) en la fila que se sitúa más abajo del centro de la página oficial. Cerasale. Marzo 02, 2009.
EPARs for authorised medicinal products for human use - Mimpara
Active Substance
cinacalcet (as hydrochloride)
International Nonproprietary Name or Common Name
Cinacalcet
Pharmaco-therapeutic Group
Anti-parathyroid agents
ATC Code
H05BX01
Therapeutic Indication:
Treatment of secondary hyperparathyroidism (HPT) in patients with end-stage renal disease (ESRD) on maintenance dialysis therapy.
Mimpara may be used as part of a therapeutic regimen including phosphate binders and/or Vitamin D sterols, as appropriate
Reduction of hypercalcaemia in patients with:
- parathyroid carcinoma.
- primary HPT for whom parathyroidectomy would be indicated on the basis of serum calcium levels (as defined by relevant treatment guidelines), but in whom parathyroidectomy is not clinically appropriate or is contraindicated.
No hay comentarios:
Publicar un comentario